PRESTIGIOUS MEDICAL AND PUBLIC HEALTH JOURNAL “THE LANCET REGIONAL HEALTH” PUBLISHES PIVOTAL PHASE 3 CLINICAL STUDY ON
MIQNAF® (NAFITHROMYCIN) – A LANDMARK FOR INDIA’S ANTIBIOTIC INNOVATION

Leave a Reply

Your email address will not be published. Required fields are marked *